Employing a peptide-based kinase activity assay platform, we identified that the activity of several kinases, as tyrosine kinases (TKs) and serine/threonine kinases (STKs) were markedly augmented in PAH-PASMCs. This evidence concerns the gene MARK2 and pulmonary arterial hypertension.